Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Wanbury Ltd Performance

Today's Low
135.30
arrowIcon
Today's High
144.10
52 Wk Low
42.65
arrowIcon
52 Wk High
179.35


Open

141.95

Traded Value (Cr)

80.55 L

Prev. Close

140.1

VWAP

138.7

Volume

55,057

Face Value

10

Wanbury Ltd Fundamentals

Market Cap
₹ 461 Cr
P/E Ratio (TTM)
19.28
P/B Ratio
0.00
Debt to Equity
-5.09
ROE
-43.98 %
EPS (TTM)
7.31
Dividend Yield
0.00%
Book Value
-6.83

Click here to know more about Fundamentals

Wanbury Ltd Financials

Wanbury Ltd Financials

Wanbury Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Retail 41.81 % 39.10 % 39.53 % 38.42 %
Promoters 39.79 % 39.79 % 39.80 % 39.84 %
Others 18.22 % 21.11 % 20.67 % 21.74 %
FII 0.18 % 0.00 % 0.00 % 0.00 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Retail

41.81%

Promoters

39.79%

Others

18.22%

FII

0.18%

Mutual Funds

0.00%

Retail

39.10%

Promoters

39.79%

Others

21.11%

FII

0.00%

Mutual Funds

0.00%

Retail

39.53%

Promoters

39.80%

Others

20.67%

FII

0.00%

Mutual Funds

0.00%

Retail

38.42%

Promoters

39.84%

Others

21.74%

FII

0.00%

Mutual Funds

0.00%

Resistance and Support

₹141.68

PIVOT

resistance-arrow
Resistance
First Resistance₹145.817
Second Resistance₹151.133
Third Resistance₹155.267
support-arrow
Support
First Resistance₹136.367
Second Resistance₹132.233
Third Resistance₹126.917
RSI37.434
MACD-7.240
ADX14.955
CCI-162.324

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day55,05741,10669.55
Week75,11156,75375.87
1 Month103,53382,04480.45
6 Months55,05746,20683.92

About Wanbury Ltd

Wanbury Ltd (Formerly known Pearl Organics Limited) was incorporated in August, 1988. The Company is engaged in the business of pharmaceutical and related activities, including research. The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US. In 2007-08, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007. Pursuant to the aforesaid Order of the Hon'ble Bl FR 7,85,557 Equity Shares of face value of Rs. 10/- each of the Company were issued to the Equity Shareholders of DOCL on 17th March, 2008. Similarly, the Pharmaceutical Products of India Limited (PPIL) was merged with the Company effective from April 1, 2006. In terms of the said Scheme of Merger, the Company had issued 5,62,618 Equity Shares of face value of Rs. 10/- each to the Equity Shareholders of PPIL on 27 June, 2007, which got listed on Bombay Stock Exchange Limited and National Stock Exchange Limited respectively. The company entered into a strategic association with Bravo Healthcare Ltd and incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China. It opened its office in Zurich,Switzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year 2008. The novel product 'Cdense Gems' was launched in May, 2008. The Company completed the restructuring of the Formulation Division during the year 2013. It launched, Myotol-F, targeted at female infertility in 2013, it launched Folinine. The Company's newly launched products Myotol-F (to treat polycystic ovarian syndrome) and Cal-K2 (in prevention and management of Osteoporosis) were labelled as one of the best launches in 2014.

Managing Director

Founded

1988

NSE Symbol

WANBURY

Wanbury Ltd Management

NameDesignation
N K PuriIndependent Director
K ChandranVice Chairman & Whole Time Dir
Jitendra J GandhiCompany Sec. & Compli. Officer
Pallavi ShedgeIndependent Director
Pravin Dilip PawarIndependent Director

Wanbury Ltd News

Wanbury to discuss results
On 16 May 2024
Wanbury reports consolidated net profit of Rs 10.27 crore in the December 2023 quarter
Sales rise 15.68% to Rs 145.50 crore
Wanbury to hold board meeting
On 24 January 2024
Wanbury schedules EGM
On 18 November 2023
Wanbury reports consolidated net profit of Rs 7.36 crore in the September 2023 quarter
Sales rise 16.54% to Rs 144.46 crore
Wanbury schedules board meeting
On 20 October 2023
Wanbury to convene AGM
On 27 September 2023
Wanbury reports consolidated net profit of Rs 4.69 crore in the June 2023 quarter
Sales rise 25.10% to Rs 146.29 crore
Wanbury to discuss results
On 11 August 2023
Wanbury to announce Quarterly Result
On 11 August 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
SUNPHARMA₹ 3,58,616 Cr
₹ 1,494.65
(-1.78 %)
86.97
CIPLA₹ 1,09,708 Cr
₹ 1,358.80
(-1.87 %)
33.36
DIVISLAB₹ 1,00,611 Cr
₹ 3,789.95
(-3.50 %)
73.75
DRREDDY₹ 98,044 Cr
₹ 5,877.35
(-2.96 %)
22.59
ZYDUSLIFE₹ 97,423 Cr
₹ 968.20
(-3.72 %)
36.23

Wanbury Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Wanbury Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Wanbury Ltd's share price is ₹136.30 as of May 9, 2024

Wanbury Ltd's P/E ratio is 19.28 times as of May 9, 2024.

Wanbury Ltd's most recent financial reports indicate a price-to-book ratio of 0.00, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Wanbury Ltd's market is 462 Cr as on May 9, 2024.

The current financial records of Wanbury Ltd show a -43.98% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Wanbury Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Wanbury Ltd's 52-week high and low as of May 9, 2024 are ₹144.1 and ₹135.3 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Wanbury Ltd stands at 39.79%. During the same period, Institutional Investors have shown a slight increase in their holdings, rising from 0.00% to 0.18%.